Last updated: February 21, 2024
Sponsor: Faculdade de Motricidade Humana
Overall Status: Active - Recruiting
Phase
N/A
Condition
Covid-19
Treatment
Repeated sprint
Clinical Study ID
NCT06128941
SprintRepHipoxya
Ages 18-30 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- more than 5 years of training experience in an resistance modality;
- participates in national or international championships regularly;
- athletes convalescing from covid-19, at least 30 days after diagnosis and/or hospitaldischarge;
- manifested mild to severe symptoms;
- vaccinated or not against SARS-CoV-2;
- antigen self-test for SARS-CoV-2 negative.
Exclusion
Exclusion Criteria:
- athletes who have had an acclimatization experience or exposure to altitude lastingmore than 10 days in the last 6 months;
- contain signs or symptoms of acute covid-19;
- present a positive SARS-CoV-2 antigen self-test;
- pregnant or postpartum women;
- use anti-inflammatory or immunosuppressive medications.
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Repeated sprint
Phase:
Study Start date:
January 03, 2024
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
Faculty of Human Kinetics
Lisbon, 1495-002 Cruz-Quebrada
PortugalActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.